{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:31:31Z","timestamp":1783481491494,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jcyt.2017.08.009","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T20:02:00Z","timestamp":1507665720000},"page":"1-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The survey on cellular and tissue-engineered therapies in Europe and neighboring Eurasian countries in 2014 and 2015"],"prefix":"10.1016","volume":"20","author":[{"given":"Hilary","family":"Ireland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max H.P.","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Baldomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Baharvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Lowdell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2017.08.009_bib0010","series-title":"Stem cell therapies are still mostly theory, yet clinics are flourishing","author":"Kolata","year":"2016"},{"issue":"6","key":"10.1016\/j.jcyt.2017.08.009_bib0015","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.stem.2012.05.010","article-title":"The promise and perils of stem cell therapeutics","volume":"10","author":"Daley","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.jcyt.2017.08.009_bib0020","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMp1613723","article-title":"Clarifying stem-cell therapy's benefits and risks","volume":"376","author":"Marks","year":"2017","journal-title":"N Engl J Med"},{"issue":"3\u20134","key":"10.1016\/j.jcyt.2017.08.009_bib0025","first-page":"842","article-title":"The survey on cellular and engineered tissue therapies in Europe in 2011","volume":"20","author":"Martin","year":"2014","journal-title":"Tissue Eng Part A"},{"issue":"21\u201322","key":"10.1016\/j.jcyt.2017.08.009_bib0030","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1089\/ten.tea.2012.0169","article-title":"The survey on cellular and engineered tissue therapies in Europe in 2010","volume":"18","author":"Martin","year":"2012","journal-title":"Tissue Eng Part A"},{"issue":"17\u201318","key":"10.1016\/j.jcyt.2017.08.009_bib0035","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1089\/ten.tea.2011.0131","article-title":"The survey on cellular and engineered tissue therapies in Europe in 2009","volume":"17","author":"Martin","year":"2011","journal-title":"Tissue Eng Part A"},{"issue":"8","key":"10.1016\/j.jcyt.2017.08.009_bib0040","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1089\/ten.tea.2010.0056","article-title":"A survey on cellular and engineered tissue therapies in europe in 2008","volume":"16","author":"Martin","year":"2010","journal-title":"Tissue Eng Part A"},{"issue":"1\u20132","key":"10.1016\/j.jcyt.2017.08.009_bib0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/ten.tea.2015.0416","article-title":"The survey on cellular and engineered tissue therapies in Europe in 2013","volume":"22","author":"Martin","year":"2016","journal-title":"Tissue Eng Part A"},{"issue":"1\u20132","key":"10.1016\/j.jcyt.2017.08.009_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/ten.tea.2014.0515","article-title":"The survey on cellular and engineered tissue therapies in Europe in 2012","volume":"21","author":"Martin","year":"2015","journal-title":"Tissue Eng Part A"},{"issue":"6","key":"10.1016\/j.jcyt.2017.08.009_bib0055","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/bmt.2016.20","article-title":"Hematopoietic stem cell transplantation in Europe 2014: more than 40,000 transplants annually","volume":"51","author":"Passweg","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jcyt.2017.08.009_bib0060","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/bmt.2017.34","article-title":"Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report","volume":"52","author":"Passweg","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.009_bib0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","article-title":"The MSC: an injury drugstore","volume":"9","author":"Caplan","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.009_bib0070","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/bmt.2014.312","article-title":"Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants","volume":"50","author":"Passweg","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2017.08.009_bib0075","series-title":"The ISCT survey on MSC production methods, advancing transfusion and cellular therapies worldwide","author":"Niss","year":"2012"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.009_bib0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14730\/aaps.2014.20.1.3","article-title":"Recent advancements in autologous fat grafting","volume":"20","author":"Jeong","year":"2014","journal-title":"Arch Aesthetic Plast Surg"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.009_bib0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2217\/rme.11.119","article-title":"Human adipose-derived cells: an update on the transition to clinical translation","volume":"7","author":"Gimble","year":"2012","journal-title":"Regen Med"},{"issue":"2","key":"10.1016\/j.jcyt.2017.08.009_bib0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1615\/CritRevEukaryotGeneExpr.2015013057","article-title":"Adipose-derived stromal vascular fraction cells: update on clinical utility and efficacy","volume":"25","author":"Han","year":"2015","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.009_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00383-015-3808-7","article-title":"Characterization of vasculogenic potential of human adipose-derived endothelial cells in a three-dimensional vascularized skin substitute","volume":"32","author":"Klar","year":"2016","journal-title":"Pediatr Surg Int"},{"issue":"6","key":"10.1016\/j.jcyt.2017.08.009_bib0100","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1097\/PRS.0000000000001288","article-title":"Effects of intersyringe processing on adipose tissue and its cellular components: implications in autologous fat grafting","volume":"135","author":"Osinga","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.jcyt.2017.08.009_bib0105","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/PRS.0000000000001590","article-title":"The current state of fat grafting: a review of harvesting, processing, and injection techniques","volume":"136","author":"Strong","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.jcyt.2017.08.009_bib0110","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1432-0436.2004.07205005.x","article-title":"Establishment and in vitro differentiation of a new embryonic stem cell line from human blastocyst","volume":"72","author":"Baharvand","year":"2004","journal-title":"Differentiation"},{"issue":"1","key":"10.1016\/j.jcyt.2017.08.009_bib0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/scd.2012.0195","article-title":"Stem cell research and therapy in the Islamic republic of Iran: pioneering in the Islamic world","volume":"22","author":"Miremadi","year":"2013","journal-title":"Stem Cells Dev"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917306680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917306680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:31:42Z","timestamp":1761442302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324917306680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1465324917306680"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.08.009","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The survey on cellular and tissue-engineered therapies in Europe and neighboring Eurasian countries in 2014 and 2015","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}